Key result
CTA reveals significant CAD in ~12% of non-anginal chest pain patients, indicating potential guideline underdiagnosis.
Why the study?
NICE advises against routine testing for CAD in non-anginal chest pain, but the prevalence of significant CAD in this population using CTCA was uncertain.
What is the prevalence of significant coronary artery disease on CTCA in patients presenting with non-anginal chest pain?
Observational (n=866)
What is the prevalence of significant coronary artery disease on CTCA in patients presenting with non-anginal chest pain?
Answers are grounded in this paper and cite their sources.
Routine CTCA in patients with non-anginal chest pain identifies significant CAD in 11.5% of cases, suggesting current guidelines advising against routine testing may lead to underdiagnosis.
The National Institute for Health and Care Excellence (NICE) advise against routine testing for coronary artery disease (CAD) in patients with non-anginal chest pain (NACP). This clinical audit sought to establish the prevalence of significant CAD in this cohort using computed tomography angiography (CTCA) and evaluate differences in the prevalence of cardiovascular risk factors between those with and without obstructive coronary disease. Over 23 months, 866 patients with NACP underwent CTCA. Patients were separated into three groups for analysis depending on the degree of CAD on CTCA using the CAD-RADS (Coronary Artery Disease Reporting and Data System) scoring system; no evidence of CAD (group 1), a degree of CAD requiring medical therapy only (group 2), significant CAD defined as a CAD-RADS score 4A/B or 5 (group 3). Cardiovascular risk factors were compared between the groups. We found 11.5% had significant CAD (group 3), 58.3% required medical therapy (group 2) and 30.1% had no CAD (group 1). There were 32 patients who required coronary revascularisation. Patients in group 2 and 3 were more likely to be male (p<0.001) and older (p<0.001) when compared to patients in group 1. Patients in group 3 were more likely to be hypertensive (p=0.008) and have higher Qrisk2 scores (p<0.001) when compared with those in group 1. In conclusion, NICE guidelines for NACP may result in a significant proportion of patients with CAD being underdiagnosed, including some with severe disease requiring revascularisation. This analysis suggests age, male gender, Qrisk2 score and hypertension are predictors of CAD in this cohort.
No takes yet. Share an insight, caveat, or question.
Chick et al. (2024) conducted an observational in Non-anginal chest pain (n=866). Computed tomography angiography (CTCA) was evaluated on Prevalence of significant coronary artery disease (CAD-RADS score 4A/B or 5). Computed tomography angiography revealed that 11.5% of patients presenting with non-anginal chest pain had significant coronary artery disease, indicating potential underdiagnosis by current guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: